Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11511001 Radiolabeled anti-LAG3 antibodies for immuno-PET imaging

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Regeneron Pharmaceuticals

Current Assignee

Regeneron Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 29, 2022

Patent Application Number

17127618

Date Filed

December 18, 2020

Patent Citations

US Patent 10358495 Anti-LAG3 antibodies and uses thereof

US Patent 10905784 Radiolabeled anti-LAG3 antibodies for immuno-PET imaging

US Patent 10925971 Methods of treating PRLR positive breast cancer

US Patent 10736976 Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging

US Patent 10738124 Anti-EGFRvIII antibodies and uses thereof

US Patent 10738130 Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof

Patent Primary Examiner

CPC Code

...

Radiolabeled anti-LAG3 antibodies and their use in immuno-PET imaging are provided herein. Included are methods of detecting the presence of LAG3 proteins in a patient or sample.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11511001 Radiolabeled anti-LAG3 antibodies for immuno-PET imaging

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool